Applied Sciences· 2026Q2· Review

Modulation of the Endocannabinoid System by Cannabis sativa Bioactives in Alzheimer’s Disease: Therapeutic and Nutritional Implications

Érica Fátima Rachelle, Jaqueline Vanz, Bruna de Lima Hennig, Silvane Souza Roman et al.

0citations
Q2SCImago
2026year

Short summary

Cannabis sativa bioactives, including CBD and THC, show potential for modulating neuroinflammation, oxidative stress, and amyloid-β aggregation in Alzheimer's disease (AD), with hemp-derived products offering complementary nutritional benefits.

AI-generated from the title and abstract; the full text is not read.

TakeawaysIn the app

Key pointsIn the app

Ask the paperIn the app

The rest is in the Pofolia app

Takeaways, key points and questions to the paper; new summaries every day for your field. Free.

Get it on Google Play Download on the App Store

Field: Pharmacology

PharmacologyMedicine